Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Cabazitaxel and Hormonal Therapy Before Salvage Surgery for Prostate Cancer
NCT01531205Phase 2Terminated
- Sponsor
- Moffitt Cancer Center
- Start
- May 2012
- Primary completion
- Sep 2013
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabazitaxel ginsenoside liposome injection in prostate cancer (PCa), sponsored by Moffitt Cancer Center. Started May 2012; status: terminated.
02
Drugs
cabazitaxel ginsenoside liposome injection
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01531205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01531205.